Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Green Med Solution (BGMS) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to -$988000.0.

  • Bio Green Med Solution's Income from Continuing Operations rose 4951.46% to -$988000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year increase of 5923.61%. This contributed to the annual value of -$11.2 million for FY2024, which is 5013.08% up from last year.
  • According to the latest figures from Q3 2025, Bio Green Med Solution's Income from Continuing Operations is -$988000.0, which was up 4951.46% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Bio Green Med Solution's Income from Continuing Operations ranged from a high of $78000.0 in Q4 2021 and a low of -$7.4 million during Q4 2022
  • Over the past 5 years, Bio Green Med Solution's median Income from Continuing Operations value was -$4.1 million (recorded in 2022), while the average stood at -$3.8 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first soared by 10278.17% in 2021, then crashed by 961153.85% in 2022.
  • Over the past 5 years, Bio Green Med Solution's Income from Continuing Operations (Quarter) stood at $78000.0 in 2021, then crashed by 9611.54% to -$7.4 million in 2022, then grew by 28.95% to -$5.3 million in 2023, then soared by 41.42% to -$3.1 million in 2024, then skyrocketed by 68.01% to -$988000.0 in 2025.
  • Its last three reported values are -$988000.0 in Q3 2025, -$1.3 million for Q2 2025, and -$81000.0 during Q1 2025.